Editorial & Opinion
Solriamfetol for attention deficit hyperactivity disorder.
| العنوان: | Solriamfetol for attention deficit hyperactivity disorder. |
|---|---|
| المؤلفون: | Naguy A; Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait., El-Sheshaie A; Neuropsychiatry Department, Alexandria Faculty of Medicine, Egypt., Elsori DH; Developmental and Behavioural Paediatrician, Rhode Island Hospital, Brown University, Providence, Rhode Island, United States., Alamiri B; Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.; Tufts University, Medford, Massachusetts, USA. |
| المصدر: | CNS spectrums [CNS Spectr] 2022 Dec; Vol. 27 (6), pp. 662-663. Date of Electronic Publication: 2021 Apr 19. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Cambridge University Press Country of Publication: United States NLM ID: 9702877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-8529 (Print) Linking ISSN: 10928529 NLM ISO Abbreviation: CNS Spectr Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Nov. 2011- : New York : Cambridge University Press Original Publication: New York, NY : MBL Communications, c1996- |
| مواضيع طبية MeSH: | Attention Deficit Disorder with Hyperactivity*/drug therapy, Humans ; Carbamates ; Phenylalanine |
| فهرسة مساهمة: | Keywords: ADHD; Solriamfetol; adolescents |
| المشرفين على المادة: | 939U7C91AI (solriamfetol) 0 (Carbamates) 47E5O17Y3R (Phenylalanine) |
| تواريخ الأحداث: | Date Created: 20210419 Date Completed: 20221206 Latest Revision: 20230127 |
| رمز التحديث: | 20240829 |
| DOI: | 10.1017/S1092852921000328 |
| PMID: | 33870884 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1092-8529 |
|---|---|
| DOI: | 10.1017/S1092852921000328 |